Published in Biochem Biophys Res Commun on November 15, 2006
Mechanisms of hepatic fibrogenesis. Gastroenterology (2008) 11.98
Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev (2008) 10.28
CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. J Clin Invest (2008) 5.96
Evolving challenges in hepatic fibrosis. Nat Rev Gastroenterol Hepatol (2010) 3.30
Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch Toxicol (2013) 3.00
Fate-mapping evidence that hepatic stellate cells are epithelial progenitors in adult mouse livers. Stem Cells (2008) 2.24
Epithelial-to-mesenchymal transitions in the liver. Hepatology (2009) 1.99
Smoothened is a master regulator of adult liver repair. J Clin Invest (2013) 1.89
Hepatic stellate cells contribute to progenitor cells and liver regeneration. J Clin Invest (2014) 1.77
Viral hepatocarcinogenesis. Oncogene (2010) 1.73
Concise review: bone marrow mononuclear cells for the treatment of ischemic syndromes: medicinal product or cell transplantation? Stem Cells Transl Med (2012) 1.52
Mouse model of carbon tetrachloride induced liver fibrosis: Histopathological changes and expression of CD133 and epidermal growth factor. BMC Gastroenterol (2010) 1.49
Hepatic stem cell niches. J Clin Invest (2013) 1.29
Myofibroblastic cells function as progenitors to regenerate murine livers after partial hepatectomy. Gut (2013) 1.26
Immune interactions in hepatic fibrosis. Clin Liver Dis (2008) 1.23
Evolving concepts of liver fibrogenesis provide new diagnostic and therapeutic options. Comp Hepatol (2007) 1.22
CD133: to be or not to be, is this the real question? Am J Transl Res (2013) 1.12
The role of stem cells in liver repair and fibrosis. Int J Biochem Cell Biol (2009) 1.09
Cross-talk between Notch and Hedgehog regulates hepatic stellate cell fate in mice. Hepatology (2013) 1.07
Immortal hepatic stellate cell lines: useful tools to study hepatic stellate cell biology and function? J Cell Mol Med (2007) 1.06
Aberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicry. BMC Cancer (2012) 1.02
CD24-positive cells from normal adult mouse liver are hepatocyte progenitor cells. Stem Cells Dev (2011) 1.01
Analysis of an alternative human CD133 promoter reveals the implication of Ras/ERK pathway in tumor stem-like hallmarks. Mol Cancer (2010) 1.01
Differentiation of progenitors in the liver: a matter of local choice. J Clin Invest (2013) 1.00
Ductal plates in hepatic ductular reactions. Hypothesis and implications. III. Implications for liver pathology. Virchows Arch (2011) 0.99
Mesodermal mesenchymal cells give rise to myofibroblasts, but not epithelial cells, in mouse liver injury. Hepatology (2014) 0.99
Hepatitis C virus and hepatocarcinogenesis. Clin Mol Hepatol (2012) 0.96
Evidence for and against epithelial-to-mesenchymal transition in the liver. Am J Physiol Gastrointest Liver Physiol (2013) 0.96
Stellate cells from rat pancreas are stem cells and can contribute to liver regeneration. PLoS One (2012) 0.94
Signals and cells involved in regulating liver regeneration. Cells (2012) 0.94
Prospectively isolated cancer-associated CD10(+) fibroblasts have stronger interactions with CD133(+) colon cancer cells than with CD133(-) cancer cells. PLoS One (2010) 0.92
Upregulated CD133 expression in tumorigenesis of colon cancer cells. World J Gastroenterol (2011) 0.92
Hepatic stellate cell progenitor cells. J Gastroenterol Hepatol (2012) 0.92
Liver regeneration signature in hepatitis B virus (HBV)-associated acute liver failure identified by gene expression profiling. PLoS One (2012) 0.91
Pericyte-endothelial crosstalk: implications and opportunities for advanced cellular therapies. Transl Res (2014) 0.90
Evidence for a common progenitor of epithelial and mesenchymal components of the liver. Cell Death Differ (2013) 0.90
TRIM11 is overexpressed in high-grade gliomas and promotes proliferation, invasion, migration and glial tumor growth. Oncogene (2012) 0.89
HuR regulates gap junctional intercellular communication by controlling beta-catenin levels and adherens junction integrity. Hepatology (2009) 0.89
Bile acid-induced epidermal growth factor receptor activation in quiescent rat hepatic stellate cells can trigger both proliferation and apoptosis. J Biol Chem (2009) 0.88
Molecular mechanisms controlling the phenotype and the EMT/MET dynamics of hepatocyte. Liver Int (2014) 0.88
Gene expression profiling and secretome analysis differentiate adult-derived human liver stem/progenitor cells and human hepatic stellate cells. PLoS One (2014) 0.87
Role of tumor associated fibroblasts in human liver regeneration, cirrhosis, and cancer. Int J Hepatol (2011) 0.86
Mechanisms of fibrogenesis in liver cirrhosis: The molecular aspects of epithelial-mesenchymal transition. World J Hepatol (2014) 0.85
Clinical significance and gene expression study of human hepatic stellate cells in HBV related-hepatocellular carcinoma. J Exp Clin Cancer Res (2013) 0.84
Response of sinusoidal mouse liver cells to choline-deficient ethionine-supplemented diet. Comp Hepatol (2010) 0.84
All-In-One: Advanced preparation of Human Parenchymal and Non-Parenchymal Liver Cells. PLoS One (2015) 0.83
Today's hepatic stellate cells: not your father's sternzellen. Hepatology (2007) 0.82
Clinicopathological significance of cancer stem cells marked by CD133 and KAI1/CD82 expression in laryngeal squamous cell carcinoma. World J Surg Oncol (2014) 0.81
Prom1 function in development, intestinal inflammation, and intestinal tumorigenesis. Front Oncol (2014) 0.81
Isolation of CD133+ liver stem cells for clonal expansion. J Vis Exp (2011) 0.79
Transplantation of mesenchymal stem cells into the renal medulla attenuated salt-sensitive hypertension in Dahl S rat. J Mol Med (Berl) (2014) 0.78
Bile acids induce hepatic differentiation of mesenchymal stem cells. Sci Rep (2015) 0.78
The use of marine-derived bioactive compounds as potential hepatoprotective agents. Acta Pharmacol Sin (2014) 0.78
Advances in Liver Regeneration: Revisiting Hepatic Stem/Progenitor Cells and Their Origin. Stem Cells Int (2015) 0.77
The development of hepatic stellate cells in normal and abnormal human fetuses - an immunohistochemical study. Physiol Rep (2015) 0.76
Free fatty acids shift insulin-induced hepatocyte proliferation towards CD95-dependent apoptosis. J Biol Chem (2014) 0.76
The Role of Embryonic Stem Cell-expressed RAS (ERAS) in the Maintenance of Quiescent Hepatic Stellate Cells. J Biol Chem (2016) 0.76
Expression of the novel protein PTPIP51 in rat liver: an immunohistochemical study. Histochem Cell Biol (2007) 0.76
Expression kinetics of hepatic progenitor markers in cellular models of human liver development recapitulating hepatocyte and biliary cell fate commitment. Exp Biol Med (Maywood) (2016) 0.75
Liver-derived human mesenchymal stem cells: a novel therapeutic source for liver diseases. Stem Cell Res Ther (2016) 0.75
Cellular Mechanisms of Liver Regeneration and Cell-Based Therapies of Liver Diseases. Biomed Res Int (2017) 0.75
Analysis of epithelial-mesenchymal transition markers in the histogenesis of hepatic progenitor cell in HBV-related liver diseases. Diagn Pathol (2016) 0.75
Pathogenesis of Type 2 Epithelial to Mesenchymal Transition (EMT) in Renal and Hepatic Fibrosis. J Clin Med (2015) 0.75
Hepatocyte nuclear factor 4α induces a tendency of differentiation and activation of rat hepatic stellate cells. World J Gastroenterol (2015) 0.75
Alcohol Increases Liver Progenitor Populations and Induces Disease Phenotypes in Human IPSC-Derived Mature Stage Hepatic Cells. Int J Biol Sci (2016) 0.75
Comparative characteristics of laryngeal-resident mesenchymal stromal cell populations isolated from distinct sites in the rat larynx. Stem Cell Res Ther (2017) 0.75
The diversity and plasticity of adult hepatic progenitor cells and their niche. Liver Int (2017) 0.75
Sorafenib in advanced hepatocellular carcinoma. N Engl J Med (2008) 54.30
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med (2002) 36.55
Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy (2007) 20.92
Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage. Hepatology (2008) 4.53
Congenital glutamine deficiency with glutamine synthetase mutations. N Engl J Med (2005) 3.24
Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40 KD)/ribavirin. J Hepatol (2005) 3.10
Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch Toxicol (2013) 3.00
Enforced viral replication activates adaptive immunity and is essential for the control of a cytopathic virus. Nat Immunol (2011) 2.51
Rickettsia felis infection acquired in Europe and documented by polymerase chain reaction. Emerg Infect Dis (2002) 2.26
Peginterferon-alpha-2a (40KD) and ribavirin for 16 or 24 weeks in patients with genotype 2 or 3 chronic hepatitis C. Gastroenterology (2005) 2.19
Critical flicker frequency for quantification of low-grade hepatic encephalopathy. Hepatology (2002) 2.16
Liver cell death and anemia in Wilson disease involve acid sphingomyelinase and ceramide. Nat Med (2007) 2.14
iRhom2 regulation of TACE controls TNF-mediated protection against Listeria and responses to LPS. Science (2012) 2.14
An obligatory requirement for the heterotrimeric G protein Gi3 in the antiautophagic action of insulin in the liver. Proc Natl Acad Sci U S A (2007) 2.10
IFN-alpha antagonistic activity of HCV core protein involves induction of suppressor of cytokine signaling-3. FASEB J (2003) 2.00
Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity. Proc Natl Acad Sci U S A (2011) 1.98
Integrated metabolic spatial-temporal model for the prediction of ammonia detoxification during liver damage and regeneration. Hepatology (2014) 1.93
Expression and function of the bile acid receptor TGR5 in Kupffer cells. Biochem Biophys Res Commun (2008) 1.83
Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis. Hepatology (2005) 1.79
Hepatic stellate cells contribute to progenitor cells and liver regeneration. J Clin Invest (2014) 1.77
Hepatic acute phase proteins--regulation by IL-6- and IL-1-type cytokines involving STAT3 and its crosstalk with NF-κB-dependent signaling. Eur J Cell Biol (2011) 1.71
The G-protein coupled bile salt receptor TGR5 is expressed in liver sinusoidal endothelial cells. Hepatology (2007) 1.69
Early clinical experiences with the new influenza A (H1N1/09). Dtsch Arztebl Int (2009) 1.65
Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasians. Hepatology (2010) 1.65
Disruption of hepatocellular tight junctions by vascular endothelial growth factor (VEGF): a novel mechanism for tumor invasion. J Hepatol (2004) 1.64
The membrane-bound bile acid receptor TGR5 is localized in the epithelium of human gallbladders. Hepatology (2009) 1.62
Lipopolysaccharide-induced tyrosine nitration and inactivation of hepatic glutamine synthetase in the rat. Hepatology (2005) 1.62
Ultrasound in tropical and parasitic diseases. Lancet (2003) 1.59
Processing of protein glycation, oxidation and nitrosation adducts in the liver and the effect of cirrhosis. J Hepatol (2004) 1.55
Benzodiazepine-induced protein tyrosine nitration in rat astrocytes. Hepatology (2003) 1.53
Primary HIV drug resistance and efficacy of first-line antiretroviral therapy guided by resistance testing. J Acquir Immune Defic Syndr (2006) 1.53
Involvement of NADPH oxidase isoforms and Src family kinases in CD95-dependent hepatocyte apoptosis. J Biol Chem (2005) 1.53
Portal application of autologous CD133+ bone marrow cells to the liver: a novel concept to support hepatic regeneration. Stem Cells (2005) 1.53
α5 β1-integrins are sensors for tauroursodeoxycholic acid in hepatocytes. Hepatology (2012) 1.50
Prognostic factors and early predictability of sustained viral response with peginterferon alfa-2a (40KD). J Hepatol (2002) 1.43
Vorinostat and sorafenib increase CD95 activation in gastrointestinal tumor cells through a Ca(2+)-de novo ceramide-PP2A-reactive oxygen species-dependent signaling pathway. Cancer Res (2010) 1.43
Effective T-cell recall responses require the taurine transporter Taut. Eur J Immunol (2012) 1.42
The macrophage response towards LPS and its control through the p38(MAPK)-STAT3 axis. Cell Signal (2012) 1.40
The niche of stellate cells within rat liver. Hepatology (2009) 1.40
BCL-2 family inhibitors enhance histone deacetylase inhibitor and sorafenib lethality via autophagy and overcome blockade of the extrinsic pathway to facilitate killing. Mol Pharmacol (2009) 1.38
Tissue macrophages suppress viral replication and prevent severe immunopathology in an interferon-I-dependent manner in mice. Hepatology (2010) 1.33
Real-time imaging with the sonographic contrast agent SonoVue: differentiation between benign and malignant hepatic lesions. J Ultrasound Med (2004) 1.31
Sorafenib activates CD95 and promotes autophagy and cell death via Src family kinases in gastrointestinal tumor cells. Mol Cancer Ther (2010) 1.31
Hepatic stem cell niches. J Clin Invest (2013) 1.29
Regulation of suppressor of cytokine signaling 3 (SOCS3) mRNA stability by TNF-alpha involves activation of the MKK6/p38MAPK/MK2 cascade. J Immunol (2007) 1.27
Hepatic encephalopathy and fitness to drive. Gastroenterology (2009) 1.26
Bile salt-induced apoptosis involves NADPH oxidase isoform activation. Gastroenterology (2005) 1.24
Co-reactivity of plasmodial histidine-rich protein 2 and aldolase on a combined immuno-chromographic-malaria dipstick (ICT) as a potential semi-quantitative marker of high Plasmodium falciparum parasitaemia. Parasitol Res (2004) 1.24
Caspase 9-dependent killing of hepatic stellate cells by activated Kupffer cells. Gastroenterology (2002) 1.23
Disruption of the taurine transporter gene (taut) leads to retinal degeneration in mice. FASEB J (2001) 1.21
Involvement of Toso in activation of monocytes, macrophages, and granulocytes. Proc Natl Acad Sci U S A (2013) 1.19
Hypoosmotic swelling and ammonia increase oxidative stress by NADPH oxidase in cultured astrocytes and vital brain slices. Glia (2007) 1.16
Treatment of chronic hepatitis delta with pegylated interferon-alpha2b. Liver Int (2006) 1.16
Phenotype of the taurine transporter knockout mouse. Methods Enzymol (2007) 1.16
Bile acid-induced arrhythmia is mediated by muscarinic M2 receptors in neonatal rat cardiomyocytes. PLoS One (2010) 1.15
Hyperosmolarity and CD95L trigger CD95/EGF receptor association and tyrosine phosphorylation of CD95 as prerequisites for CD95 membrane trafficking and DISC formation. FASEB J (2003) 1.14
Trafficking of the bile salt export pump from the Golgi to the canalicular membrane is regulated by the p38 MAP kinase. Gastroenterology (2004) 1.13
Reversible inhibition of mammalian glutamine synthetase by tyrosine nitration. FEBS Lett (2006) 1.12
The bile acid receptor TGR5 (Gpbar-1) acts as a neurosteroid receptor in brain. Glia (2010) 1.12
Late-phase pulse-inversion sonography using the contrast agent levovist: differentiation between benign and malignant focal lesions of the liver. AJR Am J Roentgenol (2002) 1.11
Neural mechanism underlying impaired visual judgement in the dysmetabolic brain: an fMRI study. Neuroimage (2004) 1.10
Canonical Wnt signaling maintains the quiescent stage of hepatic stellate cells. Biochem Biophys Res Commun (2007) 1.09
Taurine transporter knockout depletes muscle taurine levels and results in severe skeletal muscle impairment but leaves cardiac function uncompromised. FASEB J (2004) 1.08
Mutational characterization of the bile acid receptor TGR5 in primary sclerosing cholangitis. PLoS One (2010) 1.07
Ammonia induces MK-801-sensitive nitration and phosphorylation of protein tyrosine residues in rat astrocytes. FASEB J (2002) 1.07
Correct determination of critical flicker frequency is mandatory when comparisons to other tests are made. Gut (2013) 1.06
Trends of prevalence of primary HIV drug resistance in Germany. J Antimicrob Chemother (2007) 1.06
Evaluation of acoustic radiation force impulse imaging for determination of liver stiffness using transient elastography as a reference. World J Gastroenterol (2012) 1.05
The virtual liver: state of the art and future perspectives. Arch Toxicol (2014) 1.05
Hepatitis C virus core protein induces cell proliferation and activates ERK, JNK, and p38 MAP kinases together with the MAP kinase phosphatase MKP-1 in a HepG2 Tet-Off cell line. Virology (2002) 1.05
Bile salt-induced hepatocyte apoptosis involves epidermal growth factor receptor-dependent CD95 tyrosine phosphorylation. Gastroenterology (2003) 1.05
Involvement of integrins in osmosensing and signaling toward autophagic proteolysis in rat liver. J Biol Chem (2003) 1.05
The bile salt export pump (BSEP) in health and disease. Clin Res Hepatol Gastroenterol (2012) 1.04
Enhanced insulin sensitivity of gene-targeted mice lacking functional KCNQ1. Am J Physiol Regul Integr Comp Physiol (2009) 1.04
Involvement of integrins and Src in insulin signaling toward autophagic proteolysis in rat liver. J Biol Chem (2004) 1.04
Role of HuR and p38MAPK in ultraviolet B-induced post-transcriptional regulation of COX-2 expression in the human keratinocyte cell line HaCaT. J Biol Chem (2009) 1.03
Prevention of bile acid-induced apoptosis by betaine in rat liver. Hepatology (2002) 1.02
Endocrine and paracrine role of bile acids. World J Gastroenterol (2008) 1.02
Plasmodium malariae infection in spite of previous anti-malarial medication. Parasitol Res (2007) 1.01
Hydrogen peroxide sensing and signaling by protein kinases in the cardiovascular system. Antioxid Redox Signal (2012) 1.01
Low grade cerebral edema and the pathogenesis of hepatic encephalopathy in cirrhosis. Hepatology (2006) 1.01
The membrane-bound bile acid receptor TGR5 (Gpbar-1) is localized in the primary cilium of cholangiocytes. Biol Chem (2010) 1.01
Chronic liver disease is triggered by taurine transporter knockout in the mouse. FASEB J (2006) 1.01
The osmolyte strategy of normal human keratinocytes in maintaining cell homeostasis. J Invest Dermatol (2004) 1.00
Ca2+-dependent protein kinase C isoforms induce cholestasis in rat liver. J Biol Chem (2003) 0.99
Usp18 driven enforced viral replication in dendritic cells contributes to break of immunological tolerance in autoimmune diabetes. PLoS Pathog (2013) 0.99
Hepatic and pancreatic stellate cells in focus. Biol Chem (2009) 0.99
Microglia activation in hepatic encephalopathy in rats and humans. Hepatology (2011) 0.99
Combined mutations of canalicular transporter proteins cause severe intrahepatic cholestasis of pregnancy. Gastroenterology (2006) 0.99
Perspective: TGR5 (Gpbar-1) in liver physiology and disease. Clin Res Hepatol Gastroenterol (2012) 0.98
Hyperosmotic activation of the CD95 system. Methods Enzymol (2007) 0.98